Literature DB >> 31798751

First Report of a pCys194Arg Notch 3 Mutation in a Romanian CADASIL Patient with Transient Ischemic Attacks and Patent Foramen Ovale - Case Report and Brief Review.

Adriana Octaviana Dulamea1, Ioan Cristian Lupescu1, Ioana Gabriela Lupescu2.   

Abstract

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a hereditary disease caused by mutations in NOTCH3 gene, characterized by accumulation of a toxic protein in the small and medium size arterioles. Clinical manifestations of CADASIL include lacunar infarcts or, less frequently, large artery ischemic strokes, transient ischemic attacks, dementia, migraine and psychiatric disorders. Brain magnetic resonance imaging (MRI) usually shows multiple lacunar infarcts, diffuse leukoencephalopathy and cerebral microbleeds. The authors report the case of a 39-year-old Romanian woman who presented two transient ischemic attacks manifested with aphasia, headache and mild cognitive impairment. Brain MRI showed multiple isolated and confluent bilateral supratentorial hyperintense fluid-attenuated inversion recovery (FLAIR) and apparent diffusion coefficient (ADC) areas involving the subcortical and deep white matter, but also lenticular and caudate regions and normal aspects of the brain arteries on magnetic resonance angiography (MR-angiography). Differential diagnosis with other disorders affecting small cerebral vessels was performed. Transesophageal echocardiography showed presence of patent foramen ovale (PFO), with right-to-left shunt and contrast passage at Valsalva maneuver. Genetic testing revealed a pCys194Arg heterozygous mutation with C580T>C nucleotide's change on exon 4 of NOTCH 3 gene. The authors discuss the association of CADASIL to PFO and mild cognitive impairment as well as ongoing research for a therapeutic strategy.

Entities:  

Year:  2019        PMID: 31798751      PMCID: PMC6861716          DOI: 10.26574/maedica.2019.14.3.305

Source DB:  PubMed          Journal:  Maedica (Buchar)        ISSN: 1841-9038


  18 in total

1.  Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study.

Authors:  Irene Meissner; Bijoy K Khandheria; John A Heit; George W Petty; Sheldon G Sheps; Gary L Schwartz; Jack P Whisnant; David O Wiebers; Jody L Covalt; Tanya M Petterson; Teresa J H Christianson; Yoram Agmon
Journal:  J Am Coll Cardiol       Date:  2005-12-06       Impact factor: 24.094

2.  CADASIL in central Italy: a retrospective clinical and genetic study in 229 patients.

Authors:  Silvia Bianchi; Enza Zicari; Alessandra Carluccio; Ilaria Di Donato; Francesca Pescini; Serena Nannucci; Raffaella Valenti; Michele Ragno; Domenico Inzitari; Leonardo Pantoni; Antonio Federico; Maria Teresa Dotti
Journal:  J Neurol       Date:  2014-10-26       Impact factor: 4.849

Review 3.  Notch signaling in the developing cardiovascular system.

Authors:  Kyle Niessen; Aly Karsan
Journal:  Am J Physiol Cell Physiol       Date:  2007-03-21       Impact factor: 4.249

4.  Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.

Authors: 
Journal:  Cephalalgia       Date:  2018-01       Impact factor: 6.292

5.  Effects of sapropterin on endothelium-dependent vasodilation in patients with CADASIL: a randomized controlled trial.

Authors:  Renata De Maria; Jonica Campolo; Marina Frontali; Franco Taroni; Antonio Federico; Domenico Inzitari; Alessandra Tavani; Silvia Romano; Emanuele Puca; Francesco Orzi; Ada Francia; Caterina Mariotti; Chiara Tomasello; Maria Teresa Dotti; Maria Laura Stromillo; Leonardo Pantoni; Francesca Pescini; Raffaella Valenti; Claudio Pelucchi; Marina Parolini; Oberdan Parodi
Journal:  Stroke       Date:  2014-09-02       Impact factor: 7.914

6.  Genotypic and phenotypic spectrum of CADASIL in Japan: the experience at a referral center in Kumamoto University from 1997 to 2014.

Authors:  Akihiko Ueda; Mitsuharu Ueda; Akihito Nagatoshi; Teruyuki Hirano; Takaaki Ito; Nobutaka Arai; Eiichiro Uyama; Kota Mori; Masaaki Nakamura; Satoru Shinriki; Katsuyoshi Ikeda; Yukio Ando
Journal:  J Neurol       Date:  2015-05-16       Impact factor: 4.849

7.  Advanced intimal hyperplasia without luminal narrowing of leptomeningeal arteries in CADASIL.

Authors:  Hairong Dong; Haixia Ding; Kelly Young; Mila Blaivas; Paul J Christensen; Michael M Wang
Journal:  Stroke       Date:  2013-03-12       Impact factor: 7.914

8.  Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL.

Authors:  Martin Dichgans; Hugh S Markus; Stephen Salloway; Auli Verkkoniemi; Margaret Moline; Qin Wang; Holly Posner; Hugues S Chabriat
Journal:  Lancet Neurol       Date:  2008-02-28       Impact factor: 44.182

9.  Brain microvascular accumulation and distribution of the NOTCH3 ectodomain and granular osmiophilic material in CADASIL.

Authors:  Yumi Yamamoto; Lucinda J L Craggs; Atsushi Watanabe; Trevor Booth; Johannes Attems; Roger W C Low; Arthur E Oakley; Raj N Kalaria
Journal:  J Neuropathol Exp Neurol       Date:  2013-05       Impact factor: 3.685

10.  The comparisons of phenotype and genotype between CADASIL and CADASIL-like patients and population-specific evaluation of CADASIL scale in China.

Authors:  Dan He; Daiqi Chen; Xuefei Li; Zheng Hu; Zhiyuan Yu; Wei Wang; Xiang Luo
Journal:  J Headache Pain       Date:  2016-05-20       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.